Profile
Michael J.
Simms worked as an Executive Director of Operations at Cygnus, Inc. He then worked as a Senior Vice President of Operations at Nektar Therapeutics from 2004 to 2008.
From 2009 to 2012, he worked as a Senior Vice President of Operations and Quality at Alexza Pharmaceuticals, Inc. He also worked as a Senior Vice President at Powderject Technologies BV.
Simms received his undergraduate degree from the University of Missouri and his MBA from Pepperdine University.
Former positions of Michael J. Simms
| Companies | Position | End |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 2008-01-31 |
| ALEXZA PHARMACEUTICALS, INC. | Chief Operating Officer | 2014-02-25 |
Cygnus, Inc.
 Cygnus, Inc. Medical SpecialtiesHealth Technology Cygnus, Inc. develops and manufactures glucose-monitoring devices. The company develops devices that provide data to individuals and physicians to enable them to manage diabetes. It was founded in 1985 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
| Powderject Technologies BV | Corporate Officer/Principal | - |
Training of Michael J. Simms
| University of Missouri | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| Private companies | 3 |
|---|---|
| Powderject Technologies BV | |
Cygnus, Inc.
Cygnus, Inc. Medical SpecialtiesHealth Technology Cygnus, Inc. develops and manufactures glucose-monitoring devices. The company develops devices that provide data to individuals and physicians to enable them to manage diabetes. It was founded in 1985 and is headquartered in San Francisco, CA. | Health Technology |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA. | Health Technology |
- Stock Market
- Insiders
- Michael J. Simms
